glp 1 drugs for insulin resistance GLP-1 receptor agonists Heart Benefits of GLP-1s Disappear

As weight loss with any existing pharmaceutical intervention inevitably plateaus due to putative counterregulatory mechanisms, we further hypothesized that the postulated enhanced body weight suppressive effects of combined amylin- and GLP-1R-based pharmacotherapies could be even further enhanced if the drugs were introduced in a stepwise fashion, allowing the physiological systems to adjust to and overcome the tachyphylaxis that occurs with repeated drug treatments 21,22,23

And the best part

Assessment timelines matter significantly

What are the implications of mediation discontinuation, contraindications, emerging long-term safety, and efficacy data

Neuronal failure in Alzheimers disease: a view through the oxidative stress looking-glass

However, in rodent studies, some of these medications were associated with both benign and malignant thyroid C cell tumors